United States · FDA National Drug Code directory
Felodipine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-134_788121c3-8ac5-4592-b1c7-55466b849cce
- Product NDC
- 13668-134
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Felodipine
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111128
- Source listing expiry
- 20271231
Source-listed ingredients
- FELODIPINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-134-01) · 13668-134-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-134-05) · 13668-134-05
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-134-10) · 13668-134-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-134-30) · 13668-134-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-134-90) · 13668-134-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →